Abstract Number: 2023 • 2013 ACR/ARHP Annual Meeting
IgG4-Related Midline Destructive Lesion: Expanding The Spectrum Of Organ Involvement In IgG4-Related Disease
Background/Purpose: Midline destructive lesion (MDL) is a fibroinflammatory condition involving the nose, paranasal sinuses, and palate with relentless erosion through contiguous facial structures. A variety…Abstract Number: 2024 • 2013 ACR/ARHP Annual Meeting
Elevated IgG4+ Plasmablasts In Patients With Active, Untreated IgG4-Related Disease
Background/Purpose: IgG4-delated disease (IgG4-RD) is an immune-mediate condition responsible for inflammatory lesions that can affect nearly every organ. Diagnosis is challenging as it relies upon…Abstract Number: 2025 • 2013 ACR/ARHP Annual Meeting
Distinctive Expression Profiles Of Long Intergenic Non-Coding RNA Between Polymyalgia Rheumatica and Rheumatoid Arthritis Might Contains Helpful Suggestions For Understanding and Discriminating These Diseases
Background/Purpose: There are many clinical similarities between polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA). It has been reported that the specificity for discriminating PMR from…Abstract Number: 2026 • 2013 ACR/ARHP Annual Meeting
Initial Dose Of Prednisolone For Japanese Patients With Polymyalgia Rheumatica
Background/Purpose: Polymyalgia rheumatica (PMR) is a common inflammatory condition of elderly persons. Clinical symptoms respond to low-dose glucocorticoids, but treatment is often required for several…Abstract Number: 2027 • 2013 ACR/ARHP Annual Meeting
Treatment Of Refractory Adult-Onset Still’s Disease With Abatacept : Report Of Five Cases
Background/Purpose: Adult onset Still’s disease (AOSD) is a rare disorder of unknown etiology and systemic inflammatory disorder characterized by spiking fever, arthritis, evanescent rash and…Abstract Number: 2028 • 2013 ACR/ARHP Annual Meeting
Efficacy and Safety Of Biologic Agents In Adult-Onset Still’s Disease: A Long-Term Follow-Up Of 19 Patients At a Single Referral Center
Background/Purpose: No data comparing the long-term outcome of Adult-Onset Still’s Disease (AOSD) patients treated with different biological drugs is currently available. We evaluated the efficacy…Abstract Number: 1991 • 2013 ACR/ARHP Annual Meeting
Gout In Ambulatory Care Settings In The US: 1993-2009
Background/Purpose: Gouty arthritis (gout) is primarily cared for in ambulatory care settings. Yet, there are few nationally representative data on ambulatory health care utilization of…Abstract Number: 1992 • 2013 ACR/ARHP Annual Meeting
Trends In Outpatient Treatment Of Gout In The US: From 1993 To 2009
Background/Purpose: Gouty arthritis (gout) is primarily managed in the community by primary care providers. Relatively little is known about the treatment patterns as well as…Abstract Number: 2000 • 2013 ACR/ARHP Annual Meeting
Changes In The Prevalence Of Gout In The United States General Population Between 1960 and 2010: The National Health and Nutrition Examination Surveys
Background/Purpose: Despite the widely shared impression that the prevalence of gouty arthritis (gout) has increased over time in the US few population data are available.…Abstract Number: 1989 • 2013 ACR/ARHP Annual Meeting
Determinants Of Functional Disability In Patients With Gout: Longitudinal Analysis From a Multicentre Observational Study Of The Italian Society For Rheumatology
Background/Purpose: Gout is the most prevalent arthritis and significantly impacts on function. Beside the influence of concurrent comorbidities, identifying disease-related prognostic factors may help to…Abstract Number: 1990 • 2013 ACR/ARHP Annual Meeting
Treatment Of ACUTE Gout In The Emergency Department Evaluated According To The 2012 American College Of Rheumatology Guidelines
Background/Purpose: Acute gout attacks account for a substantial number of emergency department (ED) visits. Our aim was to record acute gout treatment in the ED…Abstract Number: 1993 • 2013 ACR/ARHP Annual Meeting
Geographic Variations Of Gout Epidemiology In The United Kingdom: A Nationwide Population Study
Background/Purpose: To examine geographic variations of gout prevalence, incidence and management in the United Kingdom. Methods: We used the Clinical Practice Research Data-link (CPRD) to…Abstract Number: 1994 • 2013 ACR/ARHP Annual Meeting
Performance Of Gout Impact Scale Of The Gout Assessment Questionnaire In a Longitudinal Observational Study Of Patients With Gout
Background/Purpose: Gout Assessment Questionnaire (GAQ2.0) is a validated disease-specific measure used to evaluate patient reported outcomes in gout studies. The objective was to evaluate the…Abstract Number: 1995 • 2013 ACR/ARHP Annual Meeting
Serum Homocysteine Related To Decreased Renal Function In Chronic Gouty Patients
Background/Purpose: Homocysteine is a non-essential amino acid formed by the conversion of methionine to cysteine. Hyperhomocysteinemia is a risk factor for cardiovascular events by inducing…Abstract Number: 1996 • 2013 ACR/ARHP Annual Meeting
Racial/Ethnicity Differences In Health-Related Quality Of Life (HRQOL), Functional Ability and Health Care Utilization In Gout Patients
Background/Purpose: Due to limited/no data for race/ethnicity, our objective was to assess whether HRQOL functional ability and health care utilization in gout patients differs by…